Mangoceuticals, Inc.
MGRX
$4.91
-$0.37-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.33M | -9.13M | -9.02M | -9.21M | -7.32M |
| Total Depreciation and Amortization | 16.00K | 22.00K | 25.00K | 24.90K | 22.50K |
| Total Amortization of Deferred Charges | 464.30K | 222.70K | -- | -- | -- |
| Total Other Non-Cash Items | 2.73M | 2.31M | 1.88M | 2.19M | 1.37M |
| Change in Net Operating Assets | 682.20K | 592.20K | 936.00K | 700.00 | -19.40K |
| Cash from Operations | -5.43M | -5.98M | -6.18M | -7.00M | -5.95M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -3.50K | -44.10K |
| Sale of Property, Plant, and Equipment | 65.00K | 65.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 65.00K | 65.00K | 0.00 | -3.50K | -44.10K |
| Total Debt Issued | 187.50K | 187.50K | 87.50K | -- | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -167.50K | -167.50K | -167.50K |
| Issuance of Common Stock | 1.77M | 1.77M | 2.40M | 7.22M | 6.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.25M | 1.50M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.21M | 3.46M | 2.32M | 7.06M | 6.36M |
| Foreign Exchange rate Adjustments | -1.70K | -1.20K | -100.00 | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.16M | -2.46M | -3.86M | 56.30K | 363.40K |
